1. Home
  2. TCI vs MNPR Comparison

TCI vs MNPR Comparison

Compare TCI & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TCI

Transcontinental Realty Investors Inc.

HOLD

Current Price

$52.73

Market Cap

455.6M

Sector

Finance

ML Signal

HOLD

Logo Monopar Therapeutics Inc.

MNPR

Monopar Therapeutics Inc.

HOLD

Current Price

$70.29

Market Cap

421.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCI
MNPR
Founded
1983
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
455.6M
421.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TCI
MNPR
Price
$52.73
$70.29
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$101.42
AVG Volume (30 Days)
2.2K
365.1K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
75.87
N/A
EPS
0.65
N/A
Revenue
$48,675,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$81.12
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.50
$26.06
52 Week High
$59.65
$105.00

Technical Indicators

Market Signals
Indicator
TCI
MNPR
Relative Strength Index (RSI) 50.59 49.99
Support Level $49.91 $67.33
Resistance Level $53.94 $76.13
Average True Range (ATR) 1.72 5.37
MACD -0.45 1.07
Stochastic Oscillator 34.95 67.10

Price Performance

Historical Comparison
TCI
MNPR

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

Share on Social Networks: